Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
To determine the safety and tolerability of multiple-dose administrations of aripiprazole
intramuscular (IM) depot in the deltoid muscle in adult subjects with schizophrenia
Phase:
Phase 1
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.